5-((3-(Trifluoromethyl)benzyl)thio)-1,3,4-thiadiazol-2-amine

Catalog No. :
ACOXPC648
CAS No. :
345988-07-0
Molecular Formula :
C10H8F3N3S2
Molecular Weight :
291.32

IUPAC Name:5-((3-(trifluoromethyl)benzyl)thio)-1,3,4-thiadiazol-2-amine

5-((3-(Trifluoromethyl)benzyl)thio)-1,3,4-thiadiazol-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$136.00Login to see priceInquiryInquiry
1g95%$311.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-((3-(Trifluoromethyl)benzyl)thio)-1,3,4-thiadiazol-2-amine
IUPAC Name5-((3-(trifluoromethyl)benzyl)thio)-1,3,4-thiadiazol-2-amine
Molecular FormulaC10H8F3N3S2
Molecular Weight291.32
SMILESNC1=NN=C(SCC2=CC=CC(C(F)(F)F)=C2)S1
InChI KeyBZNBVLRJNRSLOA-UHFFFAOYSA-N
Synonym[5-[[3-(trifluoromethyl)benzyl]thio]-1,3,4-thiadiazol-2-yl]amine;5-([3-(TRIFLUOROMETHYL)BENZYL]SULFANYL)-1,3,4-THIADIAZOL-2-AMINE;5-([3-(TRIFLUOROMETHYL)BENZYL]SULFANYL)-1,3,4-THIADIAZOL-2-YLAMINE;5-[[3-(trifluoromethyl)phenyl]methylsulfanyl]-1,3,4-thiadiazol-2-amine;5-[[3-(trifluoromethyl)phenyl]methylthio]-1,3,4-thiadiazol-2-amine;5-{[3-(trifluoromethyl)benzyl]thio}-1,3,4-thiadiazol-2-amine;1,3,4-Thiadiazol-2-amine, 5-[[[3-(trifluoromethyl)phenyl]methyl]thio]-
CAS No.345988-07-0

Synthetic Route by SureRoute

1. ACOXPC648 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOXPC648 route product structure diagram
    ACOXPC648345988-07-0
Inquiry

2. ACOXPC648 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOXPC648 route product structure diagram
    ACOXPC648345988-07-0
Inquiry

Comments (0)